Two gene therapies for sickle cell disease are each worth up to $1.9 million, according to an April 12 draft evidence report from the Institute for Clinical and Economic Review.
Read the full post on Becker's Hospital Review - Healthcare News
2 gene therapies are cost effective at $1.9M: ICER draft
